Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

BACKGROUND: Daptomycin and ceftaroline (DAP-CPT) have been used for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but have rarely been compared with other therapies. This study provides an exploratory analysis of patients placed on DAP-CPT vs standard of care (SOC) for M...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: McCreary, Erin K, Kullar, Ravina, Geriak, Matthew, Zasowski, Evan J, Rizvi, Khulood, Schulz, Lucas T, Ouellette, Krista, Vasina, Logan, Haddad, Fadi, Rybak, Michael J, Zervos, Marcus J, Sakoulas, George, Rose, Warren E
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Major Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6951465/
https://ncbi.nlm.nih.gov/pubmed/31938716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz538
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires